English

More about this topic

Healthcare

Which countries in Europe pay the most for medicines?

Europeans pay different prices for medicines based on where exactly they live, but they spend way less than the US does.

Business

Novo Nordisk cuts forecast as weight-loss drug competition heats up

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth outlook for 2025 amid intensifying competition in the weight-loss drug markets.

Health news

EU Commission slams first US step towards pharmaceutical tariffs

The EU executive has condemned a US probe into pharmaceutical tariffs, warning that proposed duties could disrupt transatlantic trade.

Health news

NGOs warn of Big Pharma’s influence on EU drug reform

Several major organisations are suspicious that recent lobbying efforts by pharmaceutical companies could sway the upcoming EU pharmaceutical reform talks in favour of innovation arguments at the expense of patient access.

ADVERTISEMENT

Health news

EU holds firm on pharma reform proposal despite industry pressure

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting pressure from the pharmaceutical industry concerned about potential tariffs and the sector’s competitiveness.

Business

Swiss pharma giant Roche pledges to invest €47 billion in the US

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss pharmaceutical company.

Economy

US moves ahead with tariffs - launching pharma and chip investigations

The Trump administration has taken its next steps toward imposing more tariffs on key imports, launching investigations into imports of computer chips, chip making equipment and pharmaceuticals.

Health news

Agency flags risks to nuclear medicines from dependency on Russia, US

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA).

Business

New tariffs from the US are about to hit the pharmaceutical sector

Despite sparking global-market turmoil with last week’s announcement, the US President is promising new tariffs, now targeting the previously exempted pharmaceutical sector.

Health news

Pharma companies ask EU Commission to negotiate with US over tariffs

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs and other medical products.

Europe News

Did pharma sector dodge Trump’s tariffs? The EU's not so sure

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

Markets

Novo Nordisk shares post the biggest monthly decline since 2002

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. However, analysts remain optimistic about the shares, forecasting a potential price upside of up to 60% over the next 12 months.

Health news

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Europe News

Commission to push 'buy European' in new critical medicines act

The European Commission has proposed new rules aimed at strengthening the security of supply and availability of critical medicines, prioritising EU-based suppliers in public procurement.

Healthcare

Which critical medicines are in short supply in the EU?

The drug shortages are the result of manufacturing problems, increased demand, and other issues.

Markets

Novo Nordisk shares jump after Wegovy price cuts announced

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its weight-loss treatment Wegovy.

Health news

Commission playing catch up with US, China in life science sector

Gene therapies, multi-country clinical trials, and AI-driven personalised medicine are some of the priorities the EU executive is working on for the upcoming Life science strategy, according to details shared with member states.

Economy

Here’s why Trump’s tariffs could hit Ireland’s pharma sector hardest

The Irish economy is particularly vulnerable to US tariffs against the EU, as it exports relatively more to the US compared to other EU economies.

Health news

EU’s medicine stockpiling challenged by national security concerns

The European Union’s efforts to build a medical stockpile and strengthen health crisis preparedness face a major challenge: a blind spot over national reserves. Many member states are reluctant to share information due to security concerns.

Business

AstraZeneca reports strong results boosted by promising trials

AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products.